New to peptide terminology? Use this glossary to translate the words on product pages, research papers and lab reports into practical questions you can answer.
Use the glossary to identify what a term describes and which document can support it. A chemical identifier, a catalogue field and a laboratory finding are different kinds of information.
Chemical identity and structure
- Peptide
- A molecule built from amino-acid residues linked through peptide bonds. The term describes a broad class, not a particular biological effect.
- Amino-acid residue
- An amino-acid unit as it appears within a peptide structure. Residue order is part of the molecule’s description.
- Sequence
- The ordered residues. Read any modifications with the sequence rather than assuming the letters describe every feature of the supplied material.
- Tripeptide / pentadecapeptide
- Terms indicating three or fifteen residues respectively. Length is a structural descriptor, not a ranking of efficacy.
- Terminal modification
- A stated change at an end of the chain. A modified material should not be silently substituted for an otherwise similar description.
- Analogue / fragment
- A related structure or part of a larger molecule. The exact relationship must be understood before transferring a finding between them.
When you encounter these words on a product page, ask which are supplier-confirmed details and which describe general literature context. The distinction matters particularly when a trade name is used for more than one structural description.
Identifiers, form and composition
- CAS number
- A chemical identifier. Check that it refers to the actual form under discussion; its presence on a listing is not a batch identity test.
- Molecular formula
- The atom-count description associated with a specified chemical form. A formula borrowed from a related material can create a misleading match.
- Molecular weight
- A mass-related description of the specified molecule, with units and form stated. It should be interpreted with the structure rather than as an isolated number.
- Counterion / salt form
- An associated chemical form or ion relevant to composition. Keep the supplier’s documented terminology with the record.
- Copper complex
- A copper-associated material such as the entity discussed under GHK-Cu. Clarify the exact specification and content basis.
- Formulation
- The composition of the supplied preparation. A finished formulation and an isolated ingredient are not automatically equivalent.
For a practical application, compare the identity questions on GHK-Cu and TB-500 before relying on a matching name.
Product, stock and sample records
- Nominal content
- The amount listed for the package option. It is not automatically an independent assay of that vial.
- SKU
- A stock identifier used to distinguish a product option, including size where applicable. It helps connect ordering and documentation records.
- Batch / lot
- A grouping identified by a code. Match the full code to the supplied label and source record.
- Physical form
- How the material is supplied, such as a documented dry preparation. Do not infer all handling conditions from the name alone.
- Lyophilised
- Freeze-dried. This describes processing; it does not state a universal stability period for every condition.
- Aliquot
- A portion separated from a larger sample. Record its relationship to the original material so traceability is retained.
- Current stock batch
- The batch linked to the actual available stock. Historical records remain useful but do not automatically describe a new order.
The storage and handling guide explains how these identifiers can stay connected through receipt and laboratory records.
Analytical testing and reporting
- COA
- Certificate of analysis: a source document reporting specified findings for an identified submitted sample.
- HPLC
- High-performance liquid chromatography. The separation, detector and integration conditions matter when interpreting a result.
- LC-MS
- Liquid chromatography coupled to mass spectrometry. Read the actual conclusion rather than treating the abbreviation as a complete identity or content statement.
- Chromatogram
- Detector response over a chromatographic run. Read axes, method context and integration rather than relying on visual neatness.
- Retention time
- Time associated with a chromatographic signal under the stated conditions. It belongs to the method context.
- Mass-to-charge ratio
- The ion property measured in mass spectrometry. Interpreted mass or structural conclusions depend on the acquisition and analysis.
- Peak-area purity
- A relative chromatographic result based on selected integrated signals. It is not automatically the fraction of all powder mass that is the intended peptide.
- Measured content
- An amount determined by an assay, with a stated method, units and sample basis.
- Reporting basis
- The denominator and conditions attached to a result. Ask whether a quantity is per vial, per preparation mass or in a solution sample.
Read HPLC versus LC-MS and purity versus content when a comparison depends on these distinctions.
Study design and evidence language
- In vitro
- Work outside an intact organism, such as a cell experiment. State the model when summarising a finding.
- In vivo
- Work within a living organism. The species, experimental setting and endpoint still need to be identified.
- Mechanism
- An explanation of how an effect may occur. Distinguish the proposed explanation from what was actually observed.
- Endpoint
- The outcome a study measures. A biomarker, functional assay and clinical outcome are different endpoints.
- Comparator / control
- A reference condition that helps interpret the experiment. Read what was compared before using the conclusion.
- Exploratory analysis
- An analysis that investigates additional questions. Its role should not be hidden when a finding is summarised.
- Replication
- Further work that evaluates whether a finding can be reproduced in an appropriate context.
- Limitation
- A feature that bounds the interpretation. It is part of the result’s context, not necessarily a reason to dismiss the study.
Use the terms in a real review
A useful note could read: “The selected SKU has nominal package content; the source COA reports chromatographic purity, while measured content is not shown.” This preserves what is known and what is absent without turning one field into another.
For a paper, a note might read: “The study investigated the stated material in a cell model and measured a particular endpoint; the proposed mechanism needs to be distinguished from broader clinical outcomes.” The purpose of terminology is clearer reasoning, not more impressive-looking prose.
If a term changes meaning between two documents, stop and clarify the difference. A consistent field name can hide different units or reporting conventions. Keep the original wording and source available for the comparison.
Frequently asked questions
Does “research peptide” describe a treatment?
It identifies a research context, not an individual treatment recommendation or authorisation.
Are purity and content synonyms?
No. They concern different analytical questions and need their own reporting basis.
Where can I use this glossary next?
Open a product specification, matching COA or research paper and label each field using its actual meaning.
Sources and further reading
Technical sources support the analytical concepts; scientific findings belong to their stated study models. Examples and review worksheets in this guide are educational tools, not Peptide Place batch results.
Editorial and corrections policy · Report a factual or documentation issue
Put the explanation into practice
Choose one compound and check its name, current sizes and research summary. Then compare a related compound before opening a source report. BPC-157 and TB-500 provide a useful recovery comparison; GHK-Cu introduces the skin and collagen conversation. For different metabolic pathways, compare Retatrutide and MOTS-c.
Open the comparison tool or return to the beginner learning path.
More terms for testing and clinical research
Use these definitions beside the document you are reading. The purpose is to ask a better question, rather than treat a technical word as a quality badge.
- Co-elution
- Two or more substances emerge from a chromatographic separation at overlapping times. One apparent peak may need further investigation.
- Calibration
- Establishing the relationship between a measuring system’s response and reference values under specified conditions.
- Measurement uncertainty
- Information describing the dispersion of values that could reasonably be assigned to the measured quantity. It belongs with interpretation of the result.
- Limit of detection / limit of quantification
- The method’s capabilities for detecting a target or measuring it quantitatively. A result below a stated limit is not automatically an exact zero.
- Stability-indicating method
- A procedure suited to assessing relevant changes in a material during stability testing. The name of an instrument alone does not establish this capability.
- Adsorption
- Material attaching to a surface, such as a sample container. It differs from absorption into the interior of a material.
- Randomization
- Assigning participants to groups using a chance-based process.
- Masking / blinding
- Keeping specified participants, investigators or assessors unaware of group assignments where feasible.
- Prespecified outcome
- An outcome defined before the relevant analysis rather than selected because it looked interesting afterwards.
- Observational study
- A study that observes exposures and outcomes without assigning the intervention being investigated. An association alone does not establish cause.
- Clinical-trial phase
- A broad development stage with a particular research purpose. It is not a score for effectiveness or a statement of market approval.
- Retest date
- A date for reassessing a material under a defined system. It is not automatically interchangeable with an expiry date.
For worked explanations, read analytical method quality, peptide stability research and clinical-trial phases. The NIST traceability resource, ICH analytical-validation guidance and CONSORT reporting statement provide the more technical background.
For short answers that put these terms in context, read the common research-peptide questions, then follow the detailed guide linked from each answer.
Names and research codes: a quick reference
| Term | Meaning | Read next |
|---|---|---|
| Analogue | A structurally modified relative of another molecule. | Sequence and identity |
| Residue | An amino-acid unit within a peptide chain. | Peptide basics |
| Research code | A development identifier, such as LY3298176 for tirzepatide. | Find published studies |
| Agonist | A substance that activates a receptor in the system examined. | Receptor-specific examples |
| Batch / lot | An identifier tied to a defined material record. | Match the report codes |
| Conjugate | A molecule with an attached chemical group; the exact attachment matters. | Growth-hormone analogue comparison |
Use a term to sharpen the question, then read its full explanation. A short definition does not determine a batch identity, regulatory status or clinical finding. The specification guide connects the chemical terms; the evidence guide connects the study terms.

